SMARCA4 and non-small cell lung carcinoma: Schoenfeld et al. examined the clinicopathologic characteristics in a multivariate NSCLC analysis and determined that both SMARCA4-mutated class 1 (N = 149) and class 2 (N = 143) had worse OS vs. WT (p < 0.001) using Kaplan–Meir methods [8].